COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production.
Autor: | Nakamoto, Takato1 (AUTHOR) tnakamoto@hosp.ncgm.go.jp, Iwamoto, Noriko1 (AUTHOR), Oshiro, Yusuke2 (AUTHOR), Inamura, Natsumi2 (AUTHOR), Nemoto, Takashi2 (AUTHOR), Ide, Satohi1 (AUTHOR), Nakamura, Keiji1,3 (AUTHOR), Nomoto, Hidetoshi1 (AUTHOR), Akiyama, Yutaro1 (AUTHOR), Suzuki, Tetsuya1 (AUTHOR), Miyazato, Yusuke1 (AUTHOR), Suzuki, Michiyo1 (AUTHOR), Suzuki, Kumiko4 (AUTHOR), Kimura, Moto5 (AUTHOR), Saito, Sho1 (AUTHOR), Kutsuna, Satoshi1,6 (AUTHOR), Ohmagari, Norio1 (AUTHOR) |
---|---|
Zdroj: | BMC Infectious Diseases. 10/23/2024, Vol. 24 Issue 1, p1-9. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |